Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
31.08.2021 22:05:00

Penumbra, Inc. to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

ALAMEDA, Calif., Aug. 31, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Morgan Stanley 19th Annual Global Healthcare Conference on Tuesday, September 14, 2021.

Penumbra, Inc. Logo (PRNewsFoto/Penumbra, Inc.)

Event:     Morgan Stanley 19th Annual Global Healthcare Conference
Date:       Tuesday, September 14, 2021
Time:      11:00am EDT / 8:00am PDT

A webcast of the presentation will be available by visiting the investors' section of the company's website at www.penumbrainc.com.  The webcast will be available on the company's website for at least two weeks following the event.

About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn.

Investor Relations

Penumbra, Inc.
510-995-2461
investors@penumbrainc.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-morgan-stanley-19th-annual-global-healthcare-conference-301365519.html

SOURCE Penumbra, Inc.

Analysen zu Penumbra Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Penumbra Inc 233,50 2,37% Penumbra Inc